IHC analysis of PDOs from all patient samples demonstrated elevated expression of E-cadherin, fibronectin, and laminin, driving ECM structural modifications, thereby enhancing tumor cell migration and supporting metastatic potential. The gene discussed is LAMB2; the disease is neoplasm.